Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuerui Chen

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Chemical Communications (Cambridge, England)|May 1, 2026
Beyond the cell membrane: subcellular organelle-targeted nanomedicinesHang Chen, Shihui Zang, Yifu Chen, et al.
Journal of Affective Disorders|September 15, 2024
The impact of adverse childhood experiences on cognitive function among middle-aged and older Chinese adults: Multiple mediators of cognitive reserve and depressive symptomsSailong Shi, Wenkai Kou, Zhilin Bian, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|January 4, 2021
Improved Stability and Targeted Cytotoxicity of Epigallocatechin-3-Gallate Palmitate for Anticancer TherapyXuerui Chen, Bingbing Liu, Rongliang Tong, et al.
Biomaterials Science|August 29, 2018
FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitorZheqi Shi, Xuerui Chen, Li Zhang, et al.
ACS Biomaterials Science & Engineering|January 9, 2021
Derivative of Epigallocatechin-3-gallatea Encapsulated in ZIF-8 with Polyethylene Glycol-Folic Acid Modification for Target and pH-Responsive Drug Release in Anticancer ResearchXuerui Chen, Zheqi Shi, Rongliang Tong, et al.
Frontiers in Molecular Biosciences|January 26, 2026
A novel prognostic model based on epithelial cell progression genes identifies OAS1 as a suppressor of bladder cancer aggressivenessXu Su, Hui Yu, Miaoyu Zhang, et al.
American Journal of Cancer Research|July 15, 2024
Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcomeLiangbin Lin, Hui Yu, Xuelu Xie, et al.
Biomaterials Advances|February 3, 2023
Polydopamine-guarded metal-organic frameworks as co-delivery systems for starvation-assisted chemo-photothermal therapyLin Zhan, Xuelian Yin, Yuxi Zhang, et al.
Molecular Biomedicine|October 30, 2024
Systemic lupus erythematosus: pathogenesis and targeted therapyXu Su, Hui Yu, Qingqiang Lei, et al.
Autoimmunity Reviews|May 20, 2026
B cells in systemic lupus erythematosus: From pathogenic mechanisms to targeted therapiesXu Su, Qingqiang Lei, Xuerui Chen, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Chemical Communications (Cambridge, England)|May 1, 2026
Beyond the cell membrane: subcellular organelle-targeted nanomedicinesHang Chen, Shihui Zang, Yifu Chen, et al.
Journal of Affective Disorders|September 15, 2024
The impact of adverse childhood experiences on cognitive function among middle-aged and older Chinese adults: Multiple mediators of cognitive reserve and depressive symptomsSailong Shi, Wenkai Kou, Zhilin Bian, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|January 4, 2021
Improved Stability and Targeted Cytotoxicity of Epigallocatechin-3-Gallate Palmitate for Anticancer TherapyXuerui Chen, Bingbing Liu, Rongliang Tong, et al.
Biomaterials Science|August 29, 2018
FA-PEG decorated MOF nanoparticles as a targeted drug delivery system for controlled release of an autophagy inhibitorZheqi Shi, Xuerui Chen, Li Zhang, et al.
ACS Biomaterials Science & Engineering|January 9, 2021
Derivative of Epigallocatechin-3-gallatea Encapsulated in ZIF-8 with Polyethylene Glycol-Folic Acid Modification for Target and pH-Responsive Drug Release in Anticancer ResearchXuerui Chen, Zheqi Shi, Rongliang Tong, et al.
Frontiers in Molecular Biosciences|January 26, 2026
A novel prognostic model based on epithelial cell progression genes identifies OAS1 as a suppressor of bladder cancer aggressivenessXu Su, Hui Yu, Miaoyu Zhang, et al.
American Journal of Cancer Research|July 15, 2024
Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcomeLiangbin Lin, Hui Yu, Xuelu Xie, et al.
Biomaterials Advances|February 3, 2023
Polydopamine-guarded metal-organic frameworks as co-delivery systems for starvation-assisted chemo-photothermal therapyLin Zhan, Xuelian Yin, Yuxi Zhang, et al.
Molecular Biomedicine|October 30, 2024
Systemic lupus erythematosus: pathogenesis and targeted therapyXu Su, Hui Yu, Qingqiang Lei, et al.
Autoimmunity Reviews|May 20, 2026
B cells in systemic lupus erythematosus: From pathogenic mechanisms to targeted therapiesXu Su, Qingqiang Lei, Xuerui Chen, et al.
Pageof 4